Daniel Patrick Mackey

Daniel Patrick Mackey discloses dealings in Infant Bacterial Therapeutics AB to Finansinspektionen. We count 6 filings; the first trade dates from 27 June 2017 and the latest from 12 March 2021.

On the market, this insider has only ever bought: 5 purchases, €54k in total. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Since January 2021: 1 purchase and no sales on the market.

A typical purchase (the median) is worth €3,960. 1 out of 5 purchases came within 30 days of a purchase by at least one other insider of the same company. A cluster is several different insiders buying the same stock within a short window, a pattern studied more closely than a single purchase.

The record was last updated on 17 March 2021 with an open-market purchase (€3,391) in Infant Bacterial Therapeutics AB. Filings reach the Finansinspektionen feed a median of 3 days after the trade. The regulation allows three business days to notify a trade (MAR article 19). These figures are compiled from regulatory filings published by Finansinspektionen. They describe what insiders did and are not a recommendation.